Literature DB >> 20479085

The oligosaccharide of gonococcal lipooligosaccharide contains several epitopes that are recognized by human antibodies.

Ryohei Yamasaki1, Uichirou Yabe, Chikako Kataoka, Ushio Takeda, Shunpei Asuka.   

Abstract

Recently, we isolated human IgG from normal human sera (NHS) using lipooligosaccharide (LOS) from gonococcal strain JW31R as an affinity ligand. We provided evidence that the oligosaccharide (OS) moiety of LOS was immunogenic in humans and that NHS contains functional antibodies that bind to the branched OS. The present study aimed to identify bactericidal antibodies that bind to partial core OS structures or their adjacent sites expressed in the 3,4-branched and 2,3:3,4-dibranched neisserial LOSs. Using 15253 LOS from serum-resistant gonococcal strain 15253 as an affinity ligand, we isolated IgG2 and found that this preparation contained at least three different species. (i) One IgG2 species recognized a cross-reactive epitope that is expressed on 3,4-branched and 2,3:3,4-dibranched neisserial LOSs. (ii) Another IgG2 species was specific for JW31R LOS from a pyocin-resistant gonococcal strain; this IgG-defined epitope was not shared with the aforementioned branched LOSs. (iii) The third IgG2 species bound to the "Salmonella minnesota" Rb and Re mutant lipopolysaccharides (LPSs); this IgG2 recognizes a KDOalpha2-4KDO residue at the reducing end of the carbohydrate moiety of each LPS. The IgG2 was also found to be functional and facilitated the killing of strain 15253. The current results show that neisserial LOS contains several epitopes within its OS moiety that are recognized by human antibodies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20479085      PMCID: PMC2897362          DOI: 10.1128/IAI.01445-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Immunogenicity of Neisseria gonorrhoeae lipooligosaccharide epitope 2C7, widely expressed in vivo with no immunochemical similarity to human glycosphingolipids.

Authors:  S Gulati; D P McQuillen; R E Mandrell; D B Jani; P A Rice
Journal:  J Infect Dis       Date:  1996-12       Impact factor: 5.226

Review 2.  The lipooligosaccharides of pathogenic gram-negative bacteria.

Authors:  A Preston; R E Mandrell; B W Gibson; M A Apicella
Journal:  Crit Rev Microbiol       Date:  1996       Impact factor: 7.624

3.  Complement-mediated bacterial killing assays.

Authors:  D P McQuillen; S Gulati; P A Rice
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

4.  The immune response of children to meningococcal lipooligosaccharides during disseminated disease is directed primarily against two monoclonal antibody-defined epitopes.

Authors:  M M Estabrook; C J Baker; J M Griffiss
Journal:  J Infect Dis       Date:  1993-04       Impact factor: 5.226

5.  Structural determination of oligosaccharides derived from lipooligosaccharide of Neisseria gonorrhoeae F62 by chemical, enzymatic, and two-dimensional NMR methods.

Authors:  R Yamasaki; B E Bacon; W Nasholds; H Schneider; J M Griffiss
Journal:  Biochemistry       Date:  1991-10-29       Impact factor: 3.162

6.  Antibodies to opacity proteins (Opa) correlate with a reduced risk of gonococcal salpingitis.

Authors:  F A Plummer; H Chubb; J N Simonsen; M Bosire; L Slaney; N J Nagelkerke; I Maclean; J O Ndinya-Achola; P Waiyaki; R C Brunham
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

7.  Structural analysis of lipooligosaccharide produced by Neisseria gonorrhoeae, strain MS11mk (variant A): a precursor for a gonococcal lipooligosaccharide associated with virulence.

Authors:  D E Kerwood; H Schneider; R Yamasaki
Journal:  Biochemistry       Date:  1992-12-29       Impact factor: 3.162

8.  The structural basis for pyocin resistance in Neisseria gonorrhoeae lipooligosaccharides.

Authors:  C M John; J M Griffiss; M A Apicella; R E Mandrell; B W Gibson
Journal:  J Biol Chem       Date:  1991-10-15       Impact factor: 5.157

9.  The structure of lipooligosaccharide produced by Neisseria gonorrhoeae, strain 15253, isolated from a patient with disseminated infection. Evidence for a new glycosylation pathway of the gonococcal lipooligosaccharide.

Authors:  R Yamasaki; D E Kerwood; H Schneider; K P Quinn; J M Griffiss; R E Mandrell
Journal:  J Biol Chem       Date:  1994-12-02       Impact factor: 5.157

10.  Antibody to Rmp (outer membrane protein 3) increases susceptibility to gonococcal infection.

Authors:  F A Plummer; H Chubb; J N Simonsen; M Bosire; L Slaney; I Maclean; J O Ndinya-Achola; P Waiyaki; R C Brunham
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

View more
  2 in total

Review 1.  Potential targets for next generation antimicrobial glycoconjugate vaccines.

Authors:  Francesca Micoli; Paolo Costantino; Roberto Adamo
Journal:  FEMS Microbiol Rev       Date:  2018-05-01       Impact factor: 16.408

Review 2.  Human Immune Responses and the Natural History of Neisseria gonorrhoeae Infection.

Authors:  Angela Lovett; Joseph A Duncan
Journal:  Front Immunol       Date:  2019-02-19       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.